Adoption of medications in substance abuse treatment: Priorities and strategies of single state authorities

Traci Rieckmann, Anne E. Kovas, Beth A. Rutkowski

Research output: Contribution to journalArticlepeer-review

18 Scopus citations


Research has confirmed the effectiveness of medications, when used in conjunction with ongoing counseling, to treat substance abuse disorders. This article describes a national, mixed-methods research project designed to investigate single state authorities’ (SSAs) perceptions of adoption of evidence-based practices in substance abuse treatment. Results are focused specifically on medication-assisted treatment, one of five evidence-based practices defined by the National Quality Forum. Medication-assisted treatment (MAT) is an important and effective part of comprehensive care options available to clients who are chronically ill with alcohol and other drug disorders. Despite mounting clinical evidence and increased availability, overall rates of implementation and sustained adoption of medications to treat addiction remain limited. The results illustrate that the SSA representatives who fund public treatment programs believe MAT is a priority and worthy of system-wide implementation. Current strategies utilized by SSAs to support the adoption of MAT are detailed, as are barriers to adoption and implementation.

Original languageEnglish (US)
Pages (from-to)227-238
Number of pages12
JournalJournal of psychoactive drugs
StatePublished - Sep 2010
Externally publishedYes


  • Barriers to adoption
  • Evidence-base practices
  • Facilitative factors
  • Medication-assisted treatment
  • National quality forum
  • Single state authority (SSA)

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Psychology(all)


Dive into the research topics of 'Adoption of medications in substance abuse treatment: Priorities and strategies of single state authorities'. Together they form a unique fingerprint.

Cite this